论文信息 - Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural Mesothelioma - 字舞流文

Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural Mesothelioma

M. Okada | Y. Ohe | C. Morimoto | T. Kijima | Taketo Yamada | M. Takenoyama | K. Nakagawa | T. Hida | M. Takeda | K. Aoe | N. Fujimoto | H. Yokouchi | T. Kishimoto | Y. Kaneko | M. Morise | K. Hirano | Motoyasu Kato | M. Hirokawa | Hironori Matsuki